Cargando…
Should we move to a genomic classification of neutrophilic myeloid neoplasms?
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641471/ https://www.ncbi.nlm.nih.gov/pubmed/37672387 http://dx.doi.org/10.1182/bloodadvances.2023011103 |
_version_ | 1785146775047241728 |
---|---|
author | Carreño-Tarragona, Gonzalo Álvarez-Larrán, Alberto Hernández-Boluda, Juan Carlos Ayala, Rosa Cross, Nicholas C. P. |
author_facet | Carreño-Tarragona, Gonzalo Álvarez-Larrán, Alberto Hernández-Boluda, Juan Carlos Ayala, Rosa Cross, Nicholas C. P. |
author_sort | Carreño-Tarragona, Gonzalo |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10641471 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | The American Society of Hematology |
record_format | MEDLINE/PubMed |
spelling | pubmed-106414712023-11-14 Should we move to a genomic classification of neutrophilic myeloid neoplasms? Carreño-Tarragona, Gonzalo Álvarez-Larrán, Alberto Hernández-Boluda, Juan Carlos Ayala, Rosa Cross, Nicholas C. P. Blood Adv Response The American Society of Hematology 2023-09-09 /pmc/articles/PMC10641471/ /pubmed/37672387 http://dx.doi.org/10.1182/bloodadvances.2023011103 Text en © 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Response Carreño-Tarragona, Gonzalo Álvarez-Larrán, Alberto Hernández-Boluda, Juan Carlos Ayala, Rosa Cross, Nicholas C. P. Should we move to a genomic classification of neutrophilic myeloid neoplasms? |
title | Should we move to a genomic classification of neutrophilic myeloid neoplasms? |
title_full | Should we move to a genomic classification of neutrophilic myeloid neoplasms? |
title_fullStr | Should we move to a genomic classification of neutrophilic myeloid neoplasms? |
title_full_unstemmed | Should we move to a genomic classification of neutrophilic myeloid neoplasms? |
title_short | Should we move to a genomic classification of neutrophilic myeloid neoplasms? |
title_sort | should we move to a genomic classification of neutrophilic myeloid neoplasms? |
topic | Response |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641471/ https://www.ncbi.nlm.nih.gov/pubmed/37672387 http://dx.doi.org/10.1182/bloodadvances.2023011103 |
work_keys_str_mv | AT carrenotarragonagonzalo shouldwemovetoagenomicclassificationofneutrophilicmyeloidneoplasms AT alvarezlarranalberto shouldwemovetoagenomicclassificationofneutrophilicmyeloidneoplasms AT hernandezboludajuancarlos shouldwemovetoagenomicclassificationofneutrophilicmyeloidneoplasms AT ayalarosa shouldwemovetoagenomicclassificationofneutrophilicmyeloidneoplasms AT crossnicholascp shouldwemovetoagenomicclassificationofneutrophilicmyeloidneoplasms |